SK263992A3 - Substituted derivatives of mandelic acid, a method of producing the same, their use in drugs and pharmaceutical compositions containing same - Google Patents

Substituted derivatives of mandelic acid, a method of producing the same, their use in drugs and pharmaceutical compositions containing same Download PDF

Info

Publication number
SK263992A3
SK263992A3 SK2639-92A SK263992A SK263992A3 SK 263992 A3 SK263992 A3 SK 263992A3 SK 263992 A SK263992 A SK 263992A SK 263992 A3 SK263992 A3 SK 263992A3
Authority
SK
Slovakia
Prior art keywords
formula
substituted
acid derivatives
mandelic acid
same
Prior art date
Application number
SK2639-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK279066B6 (sk
Inventor
Klaus-Helmut Mohrs
Siegfried Raddatz
Michael Matzke
Romanis Fruchtmann
Armin Hatzelmann
Christian Kohlsdorfer
Reiner Muller-Peddinghaus
Pia Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SK279066B6 publication Critical patent/SK279066B6/sk
Publication of SK263992A3 publication Critical patent/SK263992A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Measurement Of Force In General (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
  • Moulding By Coating Moulds (AREA)
  • Sewage (AREA)
SK2639-92A 1991-08-29 1992-08-26 Substituted derivatives of mandelic acid, a method of producing the same, their use in drugs and pharmaceutical compositions containing same SK263992A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4128681A DE4128681A1 (de) 1991-08-29 1991-08-29 Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
SK279066B6 SK279066B6 (sk) 1998-06-03
SK263992A3 true SK263992A3 (en) 1998-06-03

Family

ID=6439400

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2639-92A SK263992A3 (en) 1991-08-29 1992-08-26 Substituted derivatives of mandelic acid, a method of producing the same, their use in drugs and pharmaceutical compositions containing same

Country Status (21)

Country Link
US (1) US5292769A (hu)
EP (1) EP0529450B1 (hu)
JP (1) JPH05194402A (hu)
KR (1) KR930004270A (hu)
AT (1) ATE115949T1 (hu)
AU (1) AU643628B2 (hu)
CA (1) CA2076929A1 (hu)
CZ (1) CZ281501B6 (hu)
DE (2) DE4128681A1 (hu)
DK (1) DK0529450T3 (hu)
ES (1) ES2065737T3 (hu)
FI (1) FI101222B1 (hu)
GR (1) GR3015457T3 (hu)
HU (1) HU214577B (hu)
IL (1) IL102949A (hu)
MX (1) MX9204748A (hu)
MY (1) MY110206A (hu)
RU (1) RU2066315C1 (hu)
SK (1) SK263992A3 (hu)
TW (1) TW207995B (hu)
ZA (1) ZA926536B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
US5512581A (en) * 1994-07-18 1996-04-30 Abbott Laboratories Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
US8719041B2 (en) * 2002-06-10 2014-05-06 Ebay Inc. Method and system for customizing a network-based transaction facility seller application
TW200410921A (en) * 2002-11-25 2004-07-01 Hoffmann La Roche Mandelic acid derivatives
KR20070001922A (ko) 2003-12-12 2007-01-04 와이어쓰 심장혈관질환 치료에 유용한 퀴놀린
EP2086531A4 (en) 2006-11-30 2009-09-30 Amira Pharmaceuticals Inc COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS
ES2878405T3 (es) 2014-02-04 2021-11-18 Bioscience Pharma Partners Llc Uso de inhibidores de flap para reducir la lesión mediada por neuroinflamación en el sistema nervioso central

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate

Also Published As

Publication number Publication date
CA2076929A1 (en) 1993-03-01
MX9204748A (es) 1993-02-01
EP0529450A1 (de) 1993-03-03
ZA926536B (en) 1993-03-05
FI101222B (fi) 1998-05-15
IL102949A (en) 1997-02-18
RU2066315C1 (ru) 1996-09-10
DE4128681A1 (de) 1993-03-04
AU643628B2 (en) 1993-11-18
DE59201013D1 (de) 1995-02-02
CZ263992A3 (en) 1993-08-11
JPH05194402A (ja) 1993-08-03
GR3015457T3 (en) 1995-06-30
HU9202780D0 (en) 1992-12-28
TW207995B (hu) 1993-06-21
US5292769A (en) 1994-03-08
HU214577B (hu) 1998-04-28
HUT67137A (en) 1995-02-28
ES2065737T3 (es) 1995-02-16
CZ281501B6 (cs) 1996-10-16
KR930004270A (ko) 1993-03-22
EP0529450B1 (de) 1994-12-21
IL102949A0 (en) 1993-01-31
MY110206A (en) 1998-02-28
DK0529450T3 (da) 1995-05-15
FI923841A (fi) 1993-03-01
FI923841A0 (fi) 1992-08-27
AU2137192A (en) 1993-03-04
SK279066B6 (sk) 1998-06-03
ATE115949T1 (de) 1995-01-15
FI101222B1 (fi) 1998-05-15

Similar Documents

Publication Publication Date Title
JP2016128401A (ja) 縮合環類似体の抗線維症剤
JPH01313466A (ja) α‐置換４‐（キノリン‐２‐イル‐メトキシ）フエニル酢酸及びエステル
KR100252428B1 (ko) 리그난유사체,이의제조방법및이를함유한항지혈증제
CA2500977A1 (en) 2-thiohydantoine derivative compounds and use thereof in therapeutics
US5126354A (en) Leukotriene synthesis-inhibiting disubstituted (quinolin-2-yl-methoxy) phenylacetic acid derivatives
SK263992A3 (en) Substituted derivatives of mandelic acid, a method of producing the same, their use in drugs and pharmaceutical compositions containing same
US5192771A (en) (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents
AU2004242777A1 (en) Substituted pyrrole derivatives and their use as HMG-Co inhibitors
SK86593A3 (en) Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives
US5773465A (en) Tartronic acids, their acetalic ethers and o-esters
US5310744A (en) Quinolylmethoxyphenyl-acetamides
SK62293A3 (en) Substituted (benzothiazolyl and quinaxalyl-methoxy) phenyl-acetic acid derivatives
WO2004063148A1 (en) Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia
US5489592A (en) 3,4-dihydro-4-oxo-3-(2-propenyl)-1-phthalazineacetic acids and derivatives, their preparations and medicines containing them
JPH11349568A (ja) ラクタム誘導体及びその医薬用途
SK86693A3 (en) New isobutylsubstituted amids metansulfonyl-quinolylmeto- xyphenylcycloalkylacetic acid
EP0658550A2 (en) Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
JPH08245590A (ja) スルホンアミド誘導体及びこれを含有する医薬製剤
KR100263023B1 (ko) 혈중 지질 저하작용을 갖는 신규한 퀴놀론유도체 및 이의 제조방법
JPH07258213A (ja) 新規３−インドリル基含有アセチレン系化合物およびこれを有効成分とする抗腫瘍剤
AU2011211338A1 (en) Substituted pyrrole derivatives and their use as HMG-CO inhibitors
JPS6320823B2 (hu)
CZ355892A3 (cs) Thiazolyl-substituované deriváty kyseliny chino lyimethoxyfenyloctové